Stay updated with breaking news from Although Abivax. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS-News: ABIVAX / Key word(s): ConferenceAbivax announces presentation of four abstracts for obefazimod in ulcerative colitis and sponsorship of scientific symposium at the 19th Congress of European Crohn’s and Colitis Organization (ECCO) 13.02.2024 / 08:30 CET/CESTThe issuer is solely responsible for the content o...
EQS-News: ABIVAX / Key word(s): AGM/EGMAbivax announces its ordinary and extraordinary general meeting of June 5, 2023, and the availability of the preparatory documents 15.05.2023 / 19:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Abivax announces its ordinary and extraordinary ge...
EQS-News: ABIVAX / Key word(s): MiscellaneousAbivax: Publication of an expert article in JCC on obefazimod as promising therapeutic management option for UC patients 02.05.2023 / 18:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Abivax: Publication of an expert article in JCC on obe...
ABIVAX Abivax postpones the publication of its 2023 Universal Registration Document 28-Apr-2023 / 19:00 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer... | April 28, 2023
EQS-News: ABIVAX / Key word: Annual Results Abivax reports 2022 financial results and operations update 19.04.2023 / 21:00 CET/CEST The issuer is solely responsible for the... | April 19, 2023